Literature DB >> 18662670

Restoration of nuclear-import failure caused by triple A syndrome and oxidative stress.

Takao Kiriyama1, Makito Hirano, Hirohide Asai, Masanori Ikeda, Yoshiko Furiya, Satoshi Ueno.   

Abstract

Triple A syndrome is an autosomal recessive neurological disease, mimicking motor neuron disease, and is caused by mutant ALADIN, a nuclear-pore complex component. We recently discovered that the pathogenesis involved impaired nuclear import of DNA repair proteins, including DNA ligase I and the cerebellar ataxia causative protein aprataxin. Such impairment was overcome by fusing classical nuclear localization signal (NLS) and 137-aa downstream sequence of XRCC1, designated stretched NLS (stNLS). We report here that the minimum essential sequence of stNLS (mstNLS) is residues 239-276, downsized by more than 100 aa. mstNLS enabled efficient nuclear import of DNA repair proteins in patient fibroblasts, functioned under oxidative stress, and reduced oxidative-stress-induced cell death, more effectively than stNLS. The stress-tolerability of mstNLS was also exerted in control fibroblasts and neuroblastoma cells. These findings may help develop treatments for currently intractable triple A syndrome and other oxidative-stress-related neurological diseases, and contribute to nuclear compartmentalization study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18662670     DOI: 10.1016/j.bbrc.2008.07.088

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  XRCC1 interaction with the REV1 C-terminal domain suggests a role in post replication repair.

Authors:  Scott A Gabel; Eugene F DeRose; Robert E London
Journal:  DNA Repair (Amst)       Date:  2013-12

2.  A unique method for isolation and solubilization of proteins after extraction of RNA from tumor tissue using trizol.

Authors:  Neah Likhite; Ujjwala M Warawdekar
Journal:  J Biomol Tech       Date:  2011-04

Review 3.  Achalasia: will genetic studies provide insights?

Authors:  Henning R Gockel; Johannes Schumacher; Ines Gockel; Hauke Lang; Thomas Haaf; Markus M Nöthen
Journal:  Hum Genet       Date:  2010-08-11       Impact factor: 4.132

4.  Intracellular ROS level is increased in fibroblasts of triple A syndrome patients.

Authors:  Barbara Kind; Katrin Koehler; Manuela Krumbholz; Dana Landgraf; Angela Huebner
Journal:  J Mol Med (Berl)       Date:  2010-08-13       Impact factor: 4.599

Review 5.  The structural basis of XRCC1-mediated DNA repair.

Authors:  Robert E London
Journal:  DNA Repair (Amst)       Date:  2015-02-16

6.  Deficiency of ferritin heavy-chain nuclear import in triple a syndrome implies nuclear oxidative damage as the primary disease mechanism.

Authors:  Helen L Storr; Barbara Kind; David A Parfitt; J Paul Chapple; M Lorenz; Katrin Koehler; Angela Huebner; Adrian J L Clark
Journal:  Mol Endocrinol       Date:  2009-10-23

7.  DNA polymerase β contains a functional nuclear localization signal at its N-terminus.

Authors:  Thomas W Kirby; Natalie R Gassman; Cassandra E Smith; Ming-Lang Zhao; Julie K Horton; Samuel H Wilson; Robert E London
Journal:  Nucleic Acids Res       Date:  2017-02-28       Impact factor: 16.971

8.  Deficiency of ALADIN impairs redox homeostasis in human adrenal cells and inhibits steroidogenesis.

Authors:  R Prasad; L A Metherell; A J Clark; H L Storr
Journal:  Endocrinology       Date:  2013-07-03       Impact factor: 4.736

9.  Nuclear Localization of the DNA Repair Scaffold XRCC1: Uncovering the Functional Role of a Bipartite NLS.

Authors:  Thomas W Kirby; Natalie R Gassman; Cassandra E Smith; Lars C Pedersen; Scott A Gabel; Mack Sobhany; Samuel H Wilson; Robert E London
Journal:  Sci Rep       Date:  2015-08-25       Impact factor: 4.379

10.  The nucleoporin ALADIN regulates Aurora A localization to ensure robust mitotic spindle formation.

Authors:  Sara Carvalhal; Susana Abreu Ribeiro; Miguel Arocena; Taciana Kasciukovic; Achim Temme; Katrin Koehler; Angela Huebner; Eric R Griffis
Journal:  Mol Biol Cell       Date:  2015-08-05       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.